Date of response: 24 July 2026

Outcome: Information partially disclosed

Category: Medicines Optimisation

Request

Clinical transition pathways and precautionary alternatives for Medroxyprogesterone Acetate (Depo-Provera)

ICB Response

NN ICB 26 1681 Response Letter Final

pdf (200K)

Close
Search